 | • レポートコード：QYR2104Z1958 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、126ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療 |
| Single User | ￥546,000 (USD3,900) | ▷ お問い合わせ |
| Multi User/Five User | ￥819,000 (USD5,850) | ▷ お問い合わせ |
| Enterprise License（同一法人内共有可） | ￥1,092,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査資料では、ドキシフルリジンのグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（注射、錠剤、カプセル）、用途別市場規模（代謝抑制剤、ホルモン、抗がん剤、抗生物質）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・ドキシフルリジンの市場動向 ・企業の競争状況、市場シェア ・ドキシフルリジンの種類別市場規模（注射、錠剤、カプセル） ・ドキシフルリジンの用途別市場規模（代謝抑制剤、ホルモン、抗がん剤、抗生物質） ・ドキシフルリジンの北米市場規模2016-2027（アメリカ、カナダ） ・ドキシフルリジンのヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・ドキシフルリジンのアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・ドキシフルリジンの中南米市場規模2016-2027（メキシコ、ブラジル） ・ドキシフルリジンの中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Ipsen、Roche、Nippon Kayaku、DSM Nutritional Products AG、Jiangsu Zhengda Qingjiang Pharmaceutical、Tonghua Maoxiang Pharmaceutical、Shandong New Era Pharmaceutical、Anhui Huarun Jinchan Pharmaceutical、Jiangsu Shengdi Pharmaceutical、Shandong Xinqi Pharmaceutical、Shaanxi Dongtai Pharmaceutical、Jilin Aodong Medicine Yanji、Zhejiang Guobang Pharmaceutical、Zhejiang Haizheng Pharmaceutical、Yangtze Pharmaceutical Group、Ningbo Tianheng Pharmaceutical、Shanghai Pacific Pharmaceutical、Shanghai Zhaohui Pharmaceutical、Zibo Wanjie Pharmaceutical、Jiangsu Hengrui Pharmaceutical、Hainan General Tongmeng Pharmaceutical） ・結論 |
It is antitumor drug, is the precursor of fluorouracil (5 FU), within the tumor tissue by the effect of pyrimidine nucleoside phosphorylase, converted to free fluorouracil, thereby inhibiting tumor cell biosynthesis of DNA, RNA, shows that its anti-tumor effect. Due to the activity of the enzyme in the tumor tissue compared with normal tissue is high, so the product in tumor converted into 5 – FU speed for selective tumor. For the treatment of breast cancer, gastric cancer, colorectal cancer,
Market Analysis and Insights: Global Doxifluridine Market
The global Doxifluridine market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Doxifluridine market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Doxifluridine market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Doxifluridine market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Doxifluridine market.
Global Doxifluridine Scope and Market Size
Doxifluridine market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Doxifluridine market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Injection
Tablets
Capsule
Segment by Application
Antimetabolic Use
Hormone
Cancer Drugs
Antibiotic Medicine
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Ipsen
Roche
Nippon Kayaku
DSM Nutritional Products AG
Jiangsu Zhengda Qingjiang Pharmaceutical
Tonghua Maoxiang Pharmaceutical
Shandong New Era Pharmaceutical
Anhui Huarun Jinchan Pharmaceutical
Jiangsu Shengdi Pharmaceutical
Shandong Xinqi Pharmaceutical
Shaanxi Dongtai Pharmaceutical
Jilin Aodong Medicine Yanji
Zhejiang Guobang Pharmaceutical
Zhejiang Haizheng Pharmaceutical
Yangtze Pharmaceutical Group
Ningbo Tianheng Pharmaceutical
Shanghai Pacific Pharmaceutical
Shanghai Zhaohui Pharmaceutical
Zibo Wanjie Pharmaceutical
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Doxifluridine Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Injection
1.2.3 Tablets
1.2.4 Capsule
1.3 Market by Application
1.3.1 Global Doxifluridine Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Antimetabolic Use
1.3.3 Hormone
1.3.4 Cancer Drugs
1.3.5 Antibiotic Medicine
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Doxifluridine Market Perspective (2016-2027)
2.2 Doxifluridine Growth Trends by Regions
2.2.1 Doxifluridine Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Doxifluridine Historic Market Share by Regions (2016-2021)
2.2.3 Doxifluridine Forecasted Market Size by Regions (2022-2027)
2.3 Doxifluridine Industry Dynamic
2.3.1 Doxifluridine Market Trends
2.3.2 Doxifluridine Market Drivers
2.3.3 Doxifluridine Market Challenges
2.3.4 Doxifluridine Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Doxifluridine Players by Revenue
3.1.1 Global Top Doxifluridine Players by Revenue (2016-2021)
3.1.2 Global Doxifluridine Revenue Market Share by Players (2016-2021)
3.2 Global Doxifluridine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Doxifluridine Revenue
3.4 Global Doxifluridine Market Concentration Ratio
3.4.1 Global Doxifluridine Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Doxifluridine Revenue in 2020
3.5 Doxifluridine Key Players Head office and Area Served
3.6 Key Players Doxifluridine Product Solution and Service
3.7 Date of Enter into Doxifluridine Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Doxifluridine Breakdown Data by Type
4.1 Global Doxifluridine Historic Market Size by Type (2016-2021)
4.2 Global Doxifluridine Forecasted Market Size by Type (2022-2027)
5 Doxifluridine Breakdown Data by Application
5.1 Global Doxifluridine Historic Market Size by Application (2016-2021)
5.2 Global Doxifluridine Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Doxifluridine Market Size (2016-2027)
6.2 North America Doxifluridine Market Size by Type
6.2.1 North America Doxifluridine Market Size by Type (2016-2021)
6.2.2 North America Doxifluridine Market Size by Type (2022-2027)
6.2.3 North America Doxifluridine Market Size by Type (2016-2027)
6.3 North America Doxifluridine Market Size by Application
6.3.1 North America Doxifluridine Market Size by Application (2016-2021)
6.3.2 North America Doxifluridine Market Size by Application (2022-2027)
6.3.3 North America Doxifluridine Market Size by Application (2016-2027)
6.4 North America Doxifluridine Market Size by Country
6.4.1 North America Doxifluridine Market Size by Country (2016-2021)
6.4.2 North America Doxifluridine Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada
7 Europe
7.1 Europe Doxifluridine Market Size (2016-2027)
7.2 Europe Doxifluridine Market Size by Type
7.2.1 Europe Doxifluridine Market Size by Type (2016-2021)
7.2.2 Europe Doxifluridine Market Size by Type (2022-2027)
7.2.3 Europe Doxifluridine Market Size by Type (2016-2027)
7.3 Europe Doxifluridine Market Size by Application
7.3.1 Europe Doxifluridine Market Size by Application (2016-2021)
7.3.2 Europe Doxifluridine Market Size by Application (2022-2027)
7.3.3 Europe Doxifluridine Market Size by Application (2016-2027)
7.4 Europe Doxifluridine Market Size by Country
7.4.1 Europe Doxifluridine Market Size by Country (2016-2021)
7.4.2 Europe Doxifluridine Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Doxifluridine Market Size (2016-2027)
8.2 Asia-Pacific Doxifluridine Market Size by Type
8.2.1 Asia-Pacific Doxifluridine Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Doxifluridine Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Doxifluridine Market Size by Type (2016-2027)
8.3 Asia-Pacific Doxifluridine Market Size by Application
8.3.1 Asia-Pacific Doxifluridine Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Doxifluridine Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Doxifluridine Market Size by Application (2016-2027)
8.4 Asia-Pacific Doxifluridine Market Size by Region
8.4.1 Asia-Pacific Doxifluridine Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Doxifluridine Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Doxifluridine Market Size (2016-2027)
9.2 Latin America Doxifluridine Market Size by Type
9.2.1 Latin America Doxifluridine Market Size by Type (2016-2021)
9.2.2 Latin America Doxifluridine Market Size by Type (2022-2027)
9.2.3 Latin America Doxifluridine Market Size by Type (2016-2027)
9.3 Latin America Doxifluridine Market Size by Application
9.3.1 Latin America Doxifluridine Market Size by Application (2016-2021)
9.3.2 Latin America Doxifluridine Market Size by Application (2022-2027)
9.3.3 Latin America Doxifluridine Market Size by Application (2016-2027)
9.4 Latin America Doxifluridine Market Size by Country
9.4.1 Latin America Doxifluridine Market Size by Country (2016-2021)
9.4.2 Latin America Doxifluridine Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Doxifluridine Market Size (2016-2027)
10.2 Middle East & Africa Doxifluridine Market Size by Type
10.2.1 Middle East & Africa Doxifluridine Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Doxifluridine Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Doxifluridine Market Size by Type (2016-2027)
10.3 Middle East & Africa Doxifluridine Market Size by Application
10.3.1 Middle East & Africa Doxifluridine Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Doxifluridine Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Doxifluridine Market Size by Application (2016-2027)
10.4 Middle East & Africa Doxifluridine Market Size by Country
10.4.1 Middle East & Africa Doxifluridine Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Doxifluridine Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Ipsen
11.1.1 Ipsen Company Details
11.1.2 Ipsen Business Overview
11.1.3 Ipsen Doxifluridine Introduction
11.1.4 Ipsen Revenue in Doxifluridine Business (2016-2021)
11.1.5 Ipsen Recent Development
11.2 Roche
11.2.1 Roche Company Details
11.2.2 Roche Business Overview
11.2.3 Roche Doxifluridine Introduction
11.2.4 Roche Revenue in Doxifluridine Business (2016-2021)
11.2.5 Roche Recent Development
11.3 Nippon Kayaku
11.3.1 Nippon Kayaku Company Details
11.3.2 Nippon Kayaku Business Overview
11.3.3 Nippon Kayaku Doxifluridine Introduction
11.3.4 Nippon Kayaku Revenue in Doxifluridine Business (2016-2021)
11.3.5 Nippon Kayaku Recent Development
11.4 DSM Nutritional Products AG
11.4.1 DSM Nutritional Products AG Company Details
11.4.2 DSM Nutritional Products AG Business Overview
11.4.3 DSM Nutritional Products AG Doxifluridine Introduction
11.4.4 DSM Nutritional Products AG Revenue in Doxifluridine Business (2016-2021)
11.4.5 DSM Nutritional Products AG Recent Development
11.5 Jiangsu Zhengda Qingjiang Pharmaceutical
11.5.1 Jiangsu Zhengda Qingjiang Pharmaceutical Company Details
11.5.2 Jiangsu Zhengda Qingjiang Pharmaceutical Business Overview
11.5.3 Jiangsu Zhengda Qingjiang Pharmaceutical Doxifluridine Introduction
11.5.4 Jiangsu Zhengda Qingjiang Pharmaceutical Revenue in Doxifluridine Business (2016-2021)
11.5.5 Jiangsu Zhengda Qingjiang Pharmaceutical Recent Development
11.6 Tonghua Maoxiang Pharmaceutical
11.6.1 Tonghua Maoxiang Pharmaceutical Company Details
11.6.2 Tonghua Maoxiang Pharmaceutical Business Overview
11.6.3 Tonghua Maoxiang Pharmaceutical Doxifluridine Introduction
11.6.4 Tonghua Maoxiang Pharmaceutical Revenue in Doxifluridine Business (2016-2021)
11.6.5 Tonghua Maoxiang Pharmaceutical Recent Development
11.7 Shandong New Era Pharmaceutical
11.7.1 Shandong New Era Pharmaceutical Company Details
11.7.2 Shandong New Era Pharmaceutical Business Overview
11.7.3 Shandong New Era Pharmaceutical Doxifluridine Introduction
11.7.4 Shandong New Era Pharmaceutical Revenue in Doxifluridine Business (2016-2021)
11.7.5 Shandong New Era Pharmaceutical Recent Development
11.8 Anhui Huarun Jinchan Pharmaceutical
11.8.1 Anhui Huarun Jinchan Pharmaceutical Company Details
11.8.2 Anhui Huarun Jinchan Pharmaceutical Business Overview
11.8.3 Anhui Huarun Jinchan Pharmaceutical Doxifluridine Introduction
11.8.4 Anhui Huarun Jinchan Pharmaceutical Revenue in Doxifluridine Business (2016-2021)
11.8.5 Anhui Huarun Jinchan Pharmaceutical Recent Development
11.9 Jiangsu Shengdi Pharmaceutical
11.9.1 Jiangsu Shengdi Pharmaceutical Company Details
11.9.2 Jiangsu Shengdi Pharmaceutical Business Overview
11.9.3 Jiangsu Shengdi Pharmaceutical Doxifluridine Introduction
11.9.4 Jiangsu Shengdi Pharmaceutical Revenue in Doxifluridine Business (2016-2021)
11.9.5 Jiangsu Shengdi Pharmaceutical Recent Development
11.10 Shandong Xinqi Pharmaceutical
11.10.1 Shandong Xinqi Pharmaceutical Company Details
11.10.2 Shandong Xinqi Pharmaceutical Business Overview
11.10.3 Shandong Xinqi Pharmaceutical Doxifluridine Introduction
11.10.4 Shandong Xinqi Pharmaceutical Revenue in Doxifluridine Business (2016-2021)
11.10.5 Shandong Xinqi Pharmaceutical Recent Development
11.11 Shaanxi Dongtai Pharmaceutical
11.11.1 Shaanxi Dongtai Pharmaceutical Company Details
11.11.2 Shaanxi Dongtai Pharmaceutical Business Overview
11.11.3 Shaanxi Dongtai Pharmaceutical Doxifluridine Introduction
11.11.4 Shaanxi Dongtai Pharmaceutical Revenue in Doxifluridine Business (2016-2021)
11.11.5 Shaanxi Dongtai Pharmaceutical Recent Development
11.12 Jilin Aodong Medicine Yanji
11.12.1 Jilin Aodong Medicine Yanji Company Details
11.12.2 Jilin Aodong Medicine Yanji Business Overview
11.12.3 Jilin Aodong Medicine Yanji Doxifluridine Introduction
11.12.4 Jilin Aodong Medicine Yanji Revenue in Doxifluridine Business (2016-2021)
11.12.5 Jilin Aodong Medicine Yanji Recent Development
11.13 Zhejiang Guobang Pharmaceutical
11.13.1 Zhejiang Guobang Pharmaceutical Company Details
11.13.2 Zhejiang Guobang Pharmaceutical Business Overview
11.13.3 Zhejiang Guobang Pharmaceutical Doxifluridine Introduction
11.13.4 Zhejiang Guobang Pharmaceutical Revenue in Doxifluridine Business (2016-2021)
11.13.5 Zhejiang Guobang Pharmaceutical Recent Development
11.14 Zhejiang Haizheng Pharmaceutical
11.14.1 Zhejiang Haizheng Pharmaceutical Company Details
11.14.2 Zhejiang Haizheng Pharmaceutical Business Overview
11.14.3 Zhejiang Haizheng Pharmaceutical Doxifluridine Introduction
11.14.4 Zhejiang Haizheng Pharmaceutical Revenue in Doxifluridine Business (2016-2021)
11.14.5 Zhejiang Haizheng Pharmaceutical Recent Development
11.15 Yangtze Pharmaceutical Group
11.15.1 Yangtze Pharmaceutical Group Company Details
11.15.2 Yangtze Pharmaceutical Group Business Overview
11.15.3 Yangtze Pharmaceutical Group Doxifluridine Introduction
11.15.4 Yangtze Pharmaceutical Group Revenue in Doxifluridine Business (2016-2021)
11.15.5 Yangtze Pharmaceutical Group Recent Development
11.16 Ningbo Tianheng Pharmaceutical
11.16.1 Ningbo Tianheng Pharmaceutical Company Details
11.16.2 Ningbo Tianheng Pharmaceutical Business Overview
11.16.3 Ningbo Tianheng Pharmaceutical Doxifluridine Introduction
11.16.4 Ningbo Tianheng Pharmaceutical Revenue in Doxifluridine Business (2016-2021)
11.16.5 Ningbo Tianheng Pharmaceutical Recent Development
11.17 Shanghai Pacific Pharmaceutical
11.17.1 Shanghai Pacific Pharmaceutical Company Details
11.17.2 Shanghai Pacific Pharmaceutical Business Overview
11.17.3 Shanghai Pacific Pharmaceutical Doxifluridine Introduction
11.17.4 Shanghai Pacific Pharmaceutical Revenue in Doxifluridine Business (2016-2021)
11.17.5 Shanghai Pacific Pharmaceutical Recent Development
11.18 Shanghai Zhaohui Pharmaceutical
11.18.1 Shanghai Zhaohui Pharmaceutical Company Details
11.18.2 Shanghai Zhaohui Pharmaceutical Business Overview
11.18.3 Shanghai Zhaohui Pharmaceutical Doxifluridine Introduction
11.18.4 Shanghai Zhaohui Pharmaceutical Revenue in Doxifluridine Business (2016-2021)
11.18.5 Shanghai Zhaohui Pharmaceutical Recent Development
11.18 Zibo Wanjie Pharmaceutical
.1 Zibo Wanjie Pharmaceutical Company Details
.2 Zibo Wanjie Pharmaceutical Business Overview
.3 Zibo Wanjie Pharmaceutical Doxifluridine Introduction
.4 Zibo Wanjie Pharmaceutical Revenue in Doxifluridine Business (2016-2021)
.5 Zibo Wanjie Pharmaceutical Recent Development
11.20 Jiangsu Hengrui Pharmaceutical
11.20.1 Jiangsu Hengrui Pharmaceutical Company Details
11.20.2 Jiangsu Hengrui Pharmaceutical Business Overview
11.20.3 Jiangsu Hengrui Pharmaceutical Doxifluridine Introduction
11.20.4 Jiangsu Hengrui Pharmaceutical Revenue in Doxifluridine Business (2016-2021)
11.20.5 Jiangsu Hengrui Pharmaceutical Recent Development
11.21 Hainan General Tongmeng Pharmaceutical
11.21.1 Hainan General Tongmeng Pharmaceutical Company Details
11.21.2 Hainan General Tongmeng Pharmaceutical Business Overview
11.21.3 Hainan General Tongmeng Pharmaceutical Doxifluridine Introduction
11.21.4 Hainan General Tongmeng Pharmaceutical Revenue in Doxifluridine Business (2016-2021)
11.21.5 Hainan General Tongmeng Pharmaceutical Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Doxifluridine Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Injection
Table 3. Key Players of Tablets
Table 4. Key Players of Capsule
Table 5. Global Doxifluridine Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Doxifluridine Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Doxifluridine Market Size by Regions (2016-2021) & (US$ Million)
Table 8. Global Doxifluridine Market Share by Regions (2016-2021)
Table 9. Global Doxifluridine Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 10. Global Doxifluridine Market Share by Regions (2022-2027)
Table 11. Doxifluridine Market Trends
Table 12. Doxifluridine Market Drivers
Table 13. Doxifluridine Market Challenges
Table 14. Doxifluridine Market Restraints
Table 15. Global Doxifluridine Revenue by Players (2016-2021) & (US$ Million)
Table 16. Global Doxifluridine Market Share by Players (2016-2021)
Table 17. Global Top Doxifluridine Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Doxifluridine as of 2020)
Table 18. Ranking of Global Top Doxifluridine Companies by Revenue (US$ Million) in 2020
Table 19. Global 5 Largest Players Market Share by Doxifluridine Revenue (CR5 and HHI) & (2016-2021)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Doxifluridine Product Solution and Service
Table 22. Date of Enter into Doxifluridine Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Doxifluridine Market Size by Type (2016-2021) (US$ Million)
Table 25. Global Doxifluridine Revenue Market Share by Type (2016-2021)
Table 26. Global Doxifluridine Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 27. Global Doxifluridine Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 28. Global Doxifluridine Market Size Share by Application (2016-2021) & (US$ Million)
Table 29. Global Doxifluridine Revenue Market Share by Application (2016-2021)
Table 30. Global Doxifluridine Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 31. Global Doxifluridine Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 32. North America Doxifluridine Market Size by Type (2016-2021) (US$ Million)
Table 33. North America Doxifluridine Market Size by Type (2022-2027) & (US$ Million)
Table 34. North America Doxifluridine Market Size by Application (2016-2021) (US$ Million)
Table 35. North America Doxifluridine Market Size by Application (2022-2027) & (US$ Million)
Table 36. North America Doxifluridine Market Size by Country (2016-2021) & (US$ Million)
Table 37. North America Doxifluridine Market Size by Country (2022-2027) & (US$ Million)
Table 38. Europe Doxifluridine Market Size by Type (2016-2021) (US$ Million)
Table 39. Europe Doxifluridine Market Size by Type (2022-2027) & (US$ Million)
Table 40. Europe Doxifluridine Market Size by Application (2016-2021) (US$ Million)
Table 41. Europe Doxifluridine Market Size by Application (2022-2027) & (US$ Million)
Table 42. Europe Doxifluridine Market Size by Country (2016-2021) & (US$ Million)
Table 43. Europe Doxifluridine Market Size by Country (2022-2027) & (US$ Million)
Table 44. Asia-Pacific Doxifluridine Market Size by Type (2016-2021) (US$ Million)
Table 45. Asia-Pacific Doxifluridine Market Size by Type (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Doxifluridine Market Size by Application (2016-2021) (US$ Million)
Table 47. Asia-Pacific Doxifluridine Market Size by Application (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Doxifluridine Market Size by Region (2016-2021) & (US$ Million)
Table 49. Asia-Pacific Doxifluridine Market Size by Region (2022-2027) & (US$ Million)
Table 50. Latin America Doxifluridine Market Size by Type (2016-2021) (US$ Million)
Table 51. Latin America Doxifluridine Market Size by Type (2022-2027) & (US$ Million)
Table 52. Latin America Doxifluridine Market Size by Application (2016-2021) (US$ Million)
Table 53. Latin America Doxifluridine Market Size by Application (2022-2027) & (US$ Million)
Table 54. Latin America Doxifluridine Market Size by Country (2016-2021) & (US$ Million)
Table 55. Latin America Doxifluridine Market Size by Country (2022-2027) & (US$ Million)
Table 56. Middle East & Africa Doxifluridine Market Size by Type (2016-2021) (US$ Million)
Table 57. Middle East & Africa Doxifluridine Market Size by Type (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Doxifluridine Market Size by Application (2016-2021) (US$ Million)
Table 59. Middle East & Africa Doxifluridine Market Size by Application (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Doxifluridine Market Size by Country (2016-2021) & (US$ Million)
Table 61. Middle East & Africa Doxifluridine Market Size by Country (2022-2027) & (US$ Million)
Table 62. Ipsen Company Details
Table 63. Ipsen Business Overview
Table 64. Ipsen Doxifluridine Product
Table 65. Ipsen Revenue in Doxifluridine Business (2016-2021) & (US$ Million)
Table 66. Ipsen Recent Development
Table 67. Roche Company Details
Table 68. Roche Business Overview
Table 69. Roche Doxifluridine Product
Table 70. Roche Revenue in Doxifluridine Business (2016-2021) & (US$ Million)
Table 71. Roche Recent Development
Table 72. Nippon Kayaku Company Details
Table 73. Nippon Kayaku Business Overview
Table 74. Nippon Kayaku Doxifluridine Product
Table 75. Nippon Kayaku Revenue in Doxifluridine Business (2016-2021) & (US$ Million)
Table 76. Nippon Kayaku Recent Development
Table 77. DSM Nutritional Products AG Company Details
Table 78. DSM Nutritional Products AG Business Overview
Table 79. DSM Nutritional Products AG Doxifluridine Product
Table 80. DSM Nutritional Products AG Revenue in Doxifluridine Business (2016-2021) & (US$ Million)
Table 81. DSM Nutritional Products AG Recent Development
Table 82. Jiangsu Zhengda Qingjiang Pharmaceutical Company Details
Table 83. Jiangsu Zhengda Qingjiang Pharmaceutical Business Overview
Table 84. Jiangsu Zhengda Qingjiang Pharmaceutical Doxifluridine Product
Table 85. Jiangsu Zhengda Qingjiang Pharmaceutical Revenue in Doxifluridine Business (2016-2021) & (US$ Million)
Table 86. Jiangsu Zhengda Qingjiang Pharmaceutical Recent Development
Table 87. Tonghua Maoxiang Pharmaceutical Company Details
Table 88. Tonghua Maoxiang Pharmaceutical Business Overview
Table 89. Tonghua Maoxiang Pharmaceutical Doxifluridine Product
Table 90. Tonghua Maoxiang Pharmaceutical Revenue in Doxifluridine Business (2016-2021) & (US$ Million)
Table 91. Tonghua Maoxiang Pharmaceutical Recent Development
Table 92. Shandong New Era Pharmaceutical Company Details
Table 93. Shandong New Era Pharmaceutical Business Overview
Table 94. Shandong New Era Pharmaceutical Doxifluridine Product
Table 95. Shandong New Era Pharmaceutical Revenue in Doxifluridine Business (2016-2021) & (US$ Million)
Table 96. Shandong New Era Pharmaceutical Recent Development
Table 97. Anhui Huarun Jinchan Pharmaceutical Company Details
Table 98. Anhui Huarun Jinchan Pharmaceutical Business Overview
Table 99. Anhui Huarun Jinchan Pharmaceutical Revenue in Doxifluridine Business (2016-2021) & (US$ Million)
Table 100. Anhui Huarun Jinchan Pharmaceutical Recent Development
Table 101. Jiangsu Shengdi Pharmaceutical Company Details
Table 102. Jiangsu Shengdi Pharmaceutical Business Overview
Table 103. Jiangsu Shengdi Pharmaceutical Doxifluridine Product
Table 104. Jiangsu Shengdi Pharmaceutical Revenue in Doxifluridine Business (2016-2021) & (US$ Million)
Table 105. Jiangsu Shengdi Pharmaceutical Recent Development
Table 106. Shandong Xinqi Pharmaceutical Company Details
Table 107. Shandong Xinqi Pharmaceutical Business Overview
Table 108. Shandong Xinqi Pharmaceutical Doxifluridine Product
Table 109. Shandong Xinqi Pharmaceutical Revenue in Doxifluridine Business (2016-2021) & (US$ Million)
Table 110. Shandong Xinqi Pharmaceutical Recent Development
Table 111. Shaanxi Dongtai Pharmaceutical Company Details
Table 112. Shaanxi Dongtai Pharmaceutical Business Overview
Table 113. Shaanxi Dongtai Pharmaceutical Doxifluridine Product
Table 114. Shaanxi Dongtai Pharmaceutical Revenue in Doxifluridine Business (2016-2021) & (US$ Million)
Table 115. Shaanxi Dongtai Pharmaceutical Recent Development
Table 116. Jilin Aodong Medicine Yanji Company Details
Table 117. Jilin Aodong Medicine Yanji Business Overview
Table 118. Jilin Aodong Medicine Yanji Doxifluridine Product
Table 119. Jilin Aodong Medicine Yanji Revenue in Doxifluridine Business (2016-2021) & (US$ Million)
Table 120. Jilin Aodong Medicine Yanji Recent Development
Table 121. Zhejiang Guobang Pharmaceutical Company Details
Table 122. Zhejiang Guobang Pharmaceutical Business Overview
Table 123. Zhejiang Guobang Pharmaceutical Doxifluridine Product
Table 124. Zhejiang Guobang Pharmaceutical Revenue in Doxifluridine Business (2016-2021) & (US$ Million)
Table 125. Zhejiang Guobang Pharmaceutical Recent Development
Table 126. Zhejiang Haizheng Pharmaceutical Company Details
Table 127. Zhejiang Haizheng Pharmaceutical Business Overview
Table 128. Zhejiang Haizheng Pharmaceutical Doxifluridine Product
Table 129. Zhejiang Haizheng Pharmaceutical Revenue in Doxifluridine Business (2016-2021) & (US$ Million)
Table 130. Zhejiang Haizheng Pharmaceutical Recent Development
Table 131. Yangtze Pharmaceutical Group Company Details
Table 132. Yangtze Pharmaceutical Group Business Overview
Table 133. Yangtze Pharmaceutical Group Doxifluridine Product
Table 134. Yangtze Pharmaceutical Group Revenue in Doxifluridine Business (2016-2021) & (US$ Million)
Table 135. Yangtze Pharmaceutical Group Recent Development
Table 136. Ningbo Tianheng Pharmaceutical Company Details
Table 137. Ningbo Tianheng Pharmaceutical Business Overview
Table 138. Ningbo Tianheng Pharmaceutical Doxifluridine Product
Table 139. Ningbo Tianheng Pharmaceutical Revenue in Doxifluridine Business (2016-2021) & (US$ Million)
Table 140. Ningbo Tianheng Pharmaceutical Recent Development
Table 141. Shanghai Pacific Pharmaceutical Company Details
Table 142. Shanghai Pacific Pharmaceutical Business Overview
Table 143. Shanghai Pacific Pharmaceutical Doxifluridine Product
Table 144. Shanghai Pacific Pharmaceutical Revenue in Doxifluridine Business (2016-2021) & (US$ Million)
Table 145. Shanghai Pacific Pharmaceutical Recent Development
Table 146. Shanghai Zhaohui Pharmaceutical Company Details
Table 147. Shanghai Zhaohui Pharmaceutical Business Overview
Table 148. Shanghai Zhaohui Pharmaceutical Doxifluridine Product
Table 149. Shanghai Zhaohui Pharmaceutical Revenue in Doxifluridine Business (2016-2021) & (US$ Million)
Table 150. Shanghai Zhaohui Pharmaceutical Recent Development
Table 151. Zibo Wanjie Pharmaceutical Company Details
Table 152. Zibo Wanjie Pharmaceutical Business Overview
Table 153. Zibo Wanjie Pharmaceutical Doxifluridine Product
Table 154. Zibo Wanjie Pharmaceutical Revenue in Doxifluridine Business (2016-2021) & (US$ Million)
Table 155. Zibo Wanjie Pharmaceutical Recent Development
Table 156. Jiangsu Hengrui Pharmaceutical Company Details
Table 157. Jiangsu Hengrui Pharmaceutical Business Overview
Table 158. Jiangsu Hengrui Pharmaceutical Doxifluridine Product
Table 159. Jiangsu Hengrui Pharmaceutical Revenue in Doxifluridine Business (2016-2021) & (US$ Million)
Table 160. Jiangsu Hengrui Pharmaceutical Recent Development
Table 161. Hainan General Tongmeng Pharmaceutical Company Details
Table 162. Hainan General Tongmeng Pharmaceutical Business Overview
Table 163. Hainan General Tongmeng Pharmaceutical Doxifluridine Product
Table 164. Hainan General Tongmeng Pharmaceutical Revenue in Doxifluridine Business (2016-2021) & (US$ Million)
Table 165. Hainan General Tongmeng Pharmaceutical Recent Development
Table 166. Research Programs/Design for This Report
Table 167. Key Data Information from Secondary Sources
Table 168. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Doxifluridine Market Share by Type: 2020 VS 2027
Figure 2. Injection Features
Figure 3. Tablets Features
Figure 4. Capsule Features
Figure 5. Global Doxifluridine Market Share by Application: 2020 VS 2027
Figure 6. Antimetabolic Use Case Studies
Figure 7. Hormone Case Studies
Figure 8. Cancer Drugs Case Studies
Figure 9. Antibiotic Medicine Case Studies
Figure 10. Doxifluridine Report Years Considered
Figure 11. Global Doxifluridine Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 12. Global Doxifluridine Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 13. Global Doxifluridine Market Share by Regions: 2020 VS 2027
Figure 14. Global Doxifluridine Market Share by Regions (2022-2027)
Figure 15. Global Doxifluridine Market Share by Players in 2020
Figure 16. Global Top Doxifluridine Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Doxifluridine as of 2020
Figure 17. The Top 10 and 5 Players Market Share by Doxifluridine Revenue in 2020
Figure 18. Global Doxifluridine Revenue Market Share by Type (2016-2021)
Figure 19. Global Doxifluridine Revenue Market Share by Type (2022-2027)
Figure 20. North America Doxifluridine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 21. North America Doxifluridine Market Share by Type (2016-2027)
Figure 22. North America Doxifluridine Market Share by Application (2016-2027)
Figure 23. North America Doxifluridine Market Share by Country (2016-2027)
Figure 24. United States Doxifluridine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Canada Doxifluridine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Doxifluridine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Doxifluridine Market Share by Type (2016-2027)
Figure 28. Europe Doxifluridine Market Share by Application (2016-2027)
Figure 29. Europe Doxifluridine Market Share by Country (2016-2027)
Figure 30. Germany Doxifluridine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. France Doxifluridine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. U.K. Doxifluridine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Italy Doxifluridine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Russia Doxifluridine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Nordic Doxifluridine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Doxifluridine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Doxifluridine Market Share by Type (2016-2027)
Figure 38. Asia-Pacific Doxifluridine Market Share by Application (2016-2027)
Figure 39. Asia-Pacific Doxifluridine Market Share by Region (2016-2027)
Figure 40. China Doxifluridine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Japan Doxifluridine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. South Korea Doxifluridine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Southeast Asia Doxifluridine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. India Doxifluridine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Australia Doxifluridine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Doxifluridine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Doxifluridine Market Share by Type (2016-2027)
Figure 48. Latin America Doxifluridine Market Share by Application (2016-2027)
Figure 49. Latin America Doxifluridine Market Share by Country (2016-2027)
Figure 50. Mexico Doxifluridine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Brazil Doxifluridine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Doxifluridine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Doxifluridine Market Share by Type (2016-2027)
Figure 54. Middle East & Africa Doxifluridine Market Share by Application (2016-2027)
Figure 55. Middle East & Africa Doxifluridine Market Share by Country (2016-2027)
Figure 56. Turkey Doxifluridine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Saudi Arabia Doxifluridine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. UAE Doxifluridine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. Ipsen Revenue Growth Rate in Doxifluridine Business (2016-2021)
Figure 60. Roche Revenue Growth Rate in Doxifluridine Business (2016-2021)
Figure 61. Nippon Kayaku Revenue Growth Rate in Doxifluridine Business (2016-2021)
Figure 62. DSM Nutritional Products AG Revenue Growth Rate in Doxifluridine Business (2016-2021)
Figure 63. Jiangsu Zhengda Qingjiang Pharmaceutical Revenue Growth Rate in Doxifluridine Business (2016-2021)
Figure 64. Tonghua Maoxiang Pharmaceutical Revenue Growth Rate in Doxifluridine Business (2016-2021)
Figure 65. Shandong New Era Pharmaceutical Revenue Growth Rate in Doxifluridine Business (2016-2021)
Figure 66. Anhui Huarun Jinchan Pharmaceutical Revenue Growth Rate in Doxifluridine Business (2016-2021)
Figure 67. Jiangsu Shengdi Pharmaceutical Revenue Growth Rate in Doxifluridine Business (2016-2021)
Figure 68. Shandong Xinqi Pharmaceutical Revenue Growth Rate in Doxifluridine Business (2016-2021)
Figure 69. Shaanxi Dongtai Pharmaceutical Revenue Growth Rate in Doxifluridine Business (2016-2021)
Figure 70. Jilin Aodong Medicine Yanji Revenue Growth Rate in Doxifluridine Business (2016-2021)
Figure 71. Zhejiang Guobang Pharmaceutical Revenue Growth Rate in Doxifluridine Business (2016-2021)
Figure 72. Zhejiang Haizheng Pharmaceutical Revenue Growth Rate in Doxifluridine Business (2016-2021)
Figure 73. Yangtze Pharmaceutical Group Revenue Growth Rate in Doxifluridine Business (2016-2021)
Figure 74. Ningbo Tianheng Pharmaceutical Revenue Growth Rate in Doxifluridine Business (2016-2021)
Figure 75. Shanghai Pacific Pharmaceutical Revenue Growth Rate in Doxifluridine Business (2016-2021)
Figure 76. Shanghai Zhaohui Pharmaceutical Revenue Growth Rate in Doxifluridine Business (2016-2021)
Figure 77. Zibo Wanjie Pharmaceutical Revenue Growth Rate in Doxifluridine Business (2016-2021)
Figure 78. Jiangsu Hengrui Pharmaceutical Revenue Growth Rate in Doxifluridine Business (2016-2021)
Figure 79. Hainan General Tongmeng Pharmaceutical Revenue Growth Rate in Doxifluridine Business (2016-2021)
Figure 80. Bottom-up and Top-down Approaches for This Report
Figure 81. Data Triangulation
Figure 82. Key Executives Interviewed
世界のホルモン補充治療薬市場規模・現状・予測（2021年-2027年） Hormone replacement drugs refers to the treatment of the patients with hormone deficiency due to conditions such as dwarfism or women nearing menopause, which requires replacement of hormones in the body whose levels have become low. Market Analysis and Insights: Global Hormone Replacement Drugs Mar…- 世界の膵臓がん治療薬市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Pancreatic Cancer Treatment Drugs Market The global Pancreatic Cancer Treatment Drugs market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis and high da…
- 世界の肺がん治療薬市場規模・現状・予測（2021年-2027年） Lung Cancer Treatment Drugs are durgs used to cure lung cancer. In the coming years, it is expected that the global Lung Cancer Treatment Drugs market will advance with higher growth rate as compared to previous years. Factors such as Smoking, Rising cases of infections, Rising rates of fast growing…
- 世界の頭頸部がん治療薬/治療市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Head and Neck Cancer Drugs/Therapeutics Market The global Head and Neck Cancer Drugs/Therapeutics market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis…
- 世界のヒト成長ホルモン（hGH）市場規模・現状・予測（2021年-2027年） Growth hormone(GH),also known as somatotropin(or as human growth hormone [hGH or HGH] in its human form),is a peptide hormone that stimulates growth, cell reproduction,and cell regeneration in humans and other animals. The growing application of growth hormones in treating many diseases and conditio…